Abstract: Methods and a media system and storage system for cross-media storage coordination include but are not limited to storing a first data version of specified content based on a particular media format: storing at least a second data version of related content based on a different media format: providing a cross-reference between the first data version and the at least second data version to enable coordinated management by a designated user and/or an approved device for search and possible retrieval of the first data version and/or the at least second data version: and implementing communication access by one or more parties and/or the designated user via a communication type that is correlated with the first data version and/or the at least second data version.

Abstract: Certain aspects of the present disclosure provide apparatus and methods for balancing charge in a plurality of cells in a battery. In one example apparatus, the primary winding of the transformer may be coupled to a bus, and the secondary winding may be coupled to a cell of the plurality of cells in the battery. The apparatus also includes a switch coupled to the primary winding of the transformer and one or more control circuits coupled to the switch. The control circuit may be configured to control the first switch based on a voltage at a first terminal of the primary winding to control transfer of power between the cell and the bus via the transformer.

Abstract: The present invention relates to novel substituted bridged urea compounds, corresponding related analogs, pharmaceutical compositions and methods of use thereof. Sirtuin-modulating compounds of the present invention may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders, which include, but are not limited to, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. The present invention also related to compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

Abstract: The present invention relates to novel substituted bridged urea analog compounds of Formula (I) or pharmaceutically acceptable salts thereof, corresponding pharmaceutical compositions, processes for making and use of such compounds, alone or in combination with other therapeutic agents, as Sirtuin Modulators useful for increasing lifespan of a cell, and for use in treating and/or preventing a wide variety of diseases and disorders, which include, but are not limited to, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity.

Abstract: Devices and methods for distributing power are disclosed. For example, one device includes multiple assemblable elements, each assemblable element is configured to permit interlocking between one or more of the multiple assemblable elements. The multiple assemblable elements each include a portion of a coil. The portions of the coil are electrically interconnected and configured to provide wireless power to a receiving device.

Abstract: Optical coherence tomography (herein “OCT”) based analyte monitoring systems are disclosed. In one aspect, techniques are disclosed that can identify fluid flow in vivo (e.g., blood flow), which can act as a metric for gauging the extent of blood perfusion in tissue. For instance, if OCT is to be used to estimate the level of an analyte (e.g., glucose) in tissue, a measure of the extent of blood flow can potentially indicate the presence of an analyte correlating region, which would be suitable for analyte level estimation with OCT. Another aspect is related to systems and methods for scanning multiple regions. An optical beam is moved across the surface of the tissue in two distinct manners. The first can be a coarse scan, moving the beam to provide distinct scanning positions on the skin. The second can be a fine scan where the beam is applied for more detailed analysis.

Abstract: The present invention relates to novel substituted bridged urea compounds of Formula (I): or a pharmaceutically acceptable salt thereof, corresponding related analogs, pharmaceutical compositions and methods of use thereof. Sirtuin-modulating compounds of the present invention may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders, which include, but are not limited to, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. The present invention also related to compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

Abstract: The present disclosure describes aspects of injected conductive tattoos for powering implants. In some aspects, a system comprises a conductive tattoo used to efficiently transfer power wirelessly received from a transmitter outside a body to an electronic device in the body. The conductive tattoo is formed from a conductive material injected into an outermost permanent layer of the body. The conductive tattoo is configured to wirelessly receive and relay the power from the transmitter to the electronic device. In particular, the conductive tattoo may transfer the power to the electronic device over a coupling between the conductive tattoo and the electronic device.

Abstract: A device, method, computer program product, and network subsystem are described for associating a first mobile agent with a first security policy and a second mobile agent with a second security policy or for providing a first agent with code for responding to situational information about the first agent and about a second agent and for evaluating a received message at least in response to an indication of the first security policy and to an indication of the second security policy or for deploying the first agent.

Abstract: In one aspect, a method related to receiving, retrieving and presenting information. In addition, other method, system, and program product aspects are described in the claims, drawings, and/or text forming a part of the present disclosure.

Abstract: Certain aspects of the present disclosure are generally directed to apparatus and techniques for protecting electronic devices that may be prone to damage by wireless charging fields. For example, the apparatus may include a wireless charging circuit configured to selectively generate a wireless charging field and an impedance detection circuit coupled to the wireless charging circuit and configured to detect an impedance change corresponding to the wireless charging field. In this case, a proximity detection circuit may selectively detect proximity of one or more electronic devices that are prone to damage by the wireless charging circuit. In some aspects, detecting the proximity of the one or more electronic devices is activated based on detecting the impedance change, and wherein generating the wireless charging field comprises reducing a transmit power of the wireless charging field based on detecting the impedance change.

Abstract: An internally switched female receptacle or connector for use with IEC 60309-2 configuration plugs and the like. Various plug-latching and plug-actuated safety interlock arrangements coordinate strictly axial plug movement relative to the receptacle with the closing and opening of sleeve contacts and terminal pressure contacts. A continuous ground feature ensures grounding of the primary electrical circuit throughout plug insertion and withdrawal. An optional low-current lighting control circuit powers an LED status indicator. A modular clocking design enables variable angular positioning of the terminals during manufacture.

Abstract: Exemplary embodiments are directed to controlling impedance. A wireless power transmitter for controlling impedance comprises a transmit circuit configured to wirelessly transmit power to a plurality of receivers, each having a load resistance, within a charging region of the transmit circuit. The transmitter also comprises a controller configured to request each receiver of the plurality of receivers to adjust its load resistance to a value that achieves a target total impedance as presented to the controller.

Abstract: An apparatus and corresponding approaches for a combined energy dissipation include an energy dissipater forming a hollow chamber therein containing a partial pressure working fluid and a first adjustable thermal connector configured to be placed in an opening of the energy dissipater between an energy generating component to transfer energy there between. The first adjustable thermal connector includes a heat spreader at least partially disposed within the opening of the dissipater, an elastic member operably coupled to the energy dissipater, a flexible membrane coupled to the energy dissipater and the heat spreader, and a phase change material configured to at least partially fill an area defined by the opening, heat spreader, elastic member, and flexible membrane. Upon changing the phase change material to a first material phase, the elastic member applies a biasing force to the energy generating component to align the heat spreader with the energy generating component.

Abstract: A display (100) comprising a plurality of LED chips (604), each LED chip (604) comprising a plurality of light emitting elements (606a-c). Each LED chip (604) is arranged such that a first light emitting element (606a) is configured to illuminate a sub-pixel, and a second light emitting element (606b) is configured to illuminate a sub-pixel using substantially the same wavelength of light as the first light emitting element. There is also described an LED chip, a display pixel, a controlling method, a computer device and a computer program for a display.

Abstract: A sub-pixel for an LED display, the sub-pixel comprising a first light emitting device having a first emission beam angle and a second light emitting device having a second beam angle, the second emission beam angle being different to the first emission beam angle. There is also described a display using a plurality of the sub-pixels.

Abstract: The present invention relates to a method and system for estimating blood analyte levels using a noninvasive optical coherence tomography (OCT) based physiological monitor. An algorithm correlates OCT-based estimated blood analyte data with actual blood analyte data determined by other methods, such as invasively. OCT-based data is fit to the obtained blood analyte measurements to achieve the best correlation. Once the algorithm has generated sets of estimated blood analyte levels, it may refine the number of sets by applying one or more mathematical filters. The OCT-based physiological monitor can be calibrated using an Intensity Difference plot or the Pearson Product Moment Correlation method.

Abstract: A method for coordinating reader transmissions according to one embodiment includes, at a first reader, receiving from a second reader a request to transmit to a radio frequency identification tag; and if the first reader is transmitting, sending a denial of the request from the first reader to the second reader. A method for coordinating reader transmissions according to another embodiment includes from a first reader, sending to a plurality of readers a request to transmit to a radio frequency identification tag; waiting for responses from the plurality of readers; if a denial of the request is received by the first reader from any of the readers, not transmitting to the radio frequency identification tag; and if no denial of the request is received by the first reader from any of the readers, transmitting to the radio frequency identification tag. Additional systems, methods and computer program products are presented.

Abstract: The present invention provides a pharmaceutical composition for subcutaneous administration comprising a blood factor and a colloidal particle comprising about 0.5 to 20 mole percent of an amphipathic lipid derivatized with a biocompatible hydrophilic polymer, wherein the blood factor is not encapsulated in said colloidal particle.

Abstract: Techniques provided herein are directed toward providing an optical sensor that reduces noise from sources of light other than the LIDAR transmitter by changing the active area of the sensor of a LIDAR receiver. The optical sensor may include a two dimensional array of single photon avalanche devices (SPADs) with row-select and column-select transistors, where rows and columns are selected based on a predicted spot size and angle of reflected laser light detected at the LIDAR receiver. Among other things, this can eliminate or reduce the need for moving parts within the LIDAR receiver.